WHY ATTEND?
Whilst there has been an improved focus on Women’s Health and Femtech Innovations, the industry has yet to extend its innovative arm to the unmet needs of women at the mid-stage of life. Often described as the ‘invisible’ age bracket, the health needs of women at this pivotal life-stage have been severely neglected, reflecting a poor understanding of both the magnitude of unmet need, and the commercial potential of creating solutions.
The Women 40+ Innovation Summit, is the leading network of entrepreneurs, practitioners and industry leaders who are committed to investing in better health solutions and outcomes for women at an often challenging and transitional phase of life. As the recognised hub for innovation, collaboration and partnership, we will be exploring a broad cross-section of health concerns including menopause, perimenopause, healthy ageing (or aging well!), osteoporosis, incontinence, mental health and female -prevalent cancers.
We will be joined by: pharmaceutical companies, biotechs, start-ups, telehealth companies, HCPs, investors, top CP’s and genetic testing innovators to drive solutions, awareness and spark discussion that will facilitate the partnerships and investments needed to advance the industry.
WHIS Steering Committee 2021
Author:
Maryjane Lacoste
Maryjane Lacoste joined The Bill and Melinda Gates Foundation in May 2014, working with the Family Planning Team as the Senior Program Officer for Family Planning Service Delivery and Quality. As such, she led the implementation of the Implant Access Program and currently leads and manages the DMPA-SC introduction/scale portfolio, ensuring that the strategy focuses on expanding access to method choice and strengthens quality of care including counseling, interpersonal communications, clinical training, service delivery and performance monitoring. She also oversees the family planning portfolio in Indonesia and guides on postpartum and postabortion FP strategies. Prior to joining the Foundation, Maryjane worked with Jhpiego for over 20 years, spending the last 15 years in the field as country/regional director in Tanzania, Indonesia and Malawi. She has worked with Ministries of Health, donors and other stakeholders to develop and manage implementation of large reproductive health, maternal, newborn and child health and HIV projects in many countries in sub-Saharan Africa, as well as in Indonesia. Maryjane holds a Master of Arts degree from University of Maryland and a Bachelor of Arts degree from Loyola University.
Author:
Jarrad Aguirre
Jarrad Aguirre, MD, MBA, is Head of Corporate Strategy and Advocacy at Myovant Sciences, a healthcare company focused on women's health and prostate cancer. In this role, he oversees corporate communications, patient advocacy, and digital strategy, and serves on the Executive Committee.
Prior to joining Myovant, Jarrad worked as a physician, researcher, and consultant across the spectrum of health and healthcare, including at Brigham and Women's Hospital (a teaching hospital of Harvard Medical School), The Colorado Health Foundation, the Bill & Melinda Gates Foundation, and Collective Health.
He graduated with honors from Yale University and University of Oxford, where he studied as a Rhodes Scholar. He completed the MD/MBA at Stanford University, supported by the Jack Kent Cooke Foundation Graduate Scholarship.
Partners
Associate Partners
Essity Ventures
Website: www.essityventuresilab.com
Essity Ventures is a strategic initiative of Essity, a global health and hygiene company with a presence in more than 150 markets worldwide and leading Intimate Hygiene brands such as Bodyform, Libresse, Nana and TENA. For years, Essity has been on a mission to break barriers to women’s wellbeing with innovative feminine care products as well as bold, award-winning communications campaigns like Viva La Vulva and Wombstories to break taboos that hold women back. With Essity Ventures, the company takes one step forward in this direction, by cooperating with top-notch femtech startups to lead the way towards a more digitally-advanced and sustainable health and hygiene ecosystem. Essity Ventures is ready to explore different partnership models, committing to resources that go well beyond funding. To find out more, visit Essity Ventures website: www.essityventuresilab.com
ICON PLC
Website: https://iconplc.com/
ICON plc is a global provider of outsourced drug and device development and commercialisation services to pharmaceutical, biotechnology, medical device and government and public health organisations. The company specialises in the strategic development, management and analysis of programs that support clinical development - from compound selection to Phase I-IV clinical studies. With headquarters in Dublin, Ireland, ICON employs approximately 16,000 employees in 93 locations in 41 countries. Further information is available at www.iconplc.com.
Rosebud Woman
Website: https://rosewoman.com/
Rosebud WomanTM delivers vital support from menarche to menopause and beyond. We offer solutions for arousal, moisture, calming, freshness and resilience, and cultivate comfort and pleasure through all of the cycles in a woman’s life.
Every aspect of our product line is carefully considered to help women reclaim their vitality and alchemize joy. Our pure, plant- based formulations are effective, cruelty-free, sustainably made, hormone-free and toxin-free. Our aesthetics, designs, and sensory experiences amplify the beauty in daily life and prioritize the value of our sensations and emotions. Perfect health and pleasure are available at every age.
OBGYNS and women’s wellness professionals across the nation recommend our products, and women themselves, from all 50 US states and many countries rave about the impact they have on their daily self-care routines, and self-love rituals.
Sagentia Innovation
Website: www.sagentiainnovation.com
Sagentia Innovation provides independent advisory and leading-edge product development services focused on science and technology initiatives. Working across the medical, industrial, chemicals and energy, food and beverage, and consumer sectors, Sagentia Innovation works with a broad range of companies from some of the world’s leading and best-known brands, to start-up disruptors, new to the market. It is part of Science Group (AIM:SAG), which has more than ten offices globally, two UK-based dedicated R&D innovation centres and more than 400 employees. Other Science Group companies include Leatherhead Food Research, TSG Consulting and Frontier Smart Technologies.
Event Partner
Celanese
Website: https://bit.ly/3a0JriQ
Celanese works closely with you as a strategic partner to create innovative controlled-release dosage forms for biologics and small molecules to meet the goals of patient-centric therapies, improved medicine and better healthcare economics. Our VitalDose® EVA copolymer drug-delivery platform is an enabling technology for drug-eluting implants, inserts and transdermal films. The platform is flexible and customizable to address a variety of formulation challenges when it comes to tailoring the release rate of your drug.
- Compatible with biologics and small molecules
- Provides reliable local or systemic drug administration
- High drug loading capacity (≤ 75%)
- Engineered long-acting dosage profiles (zero-order or nonlinear profiles)
- Ease of formulation and configurable into a variety of geometries
- An established regulatory path with long clinical use history
From FEASIBILITY to DEVELOPMENT to COMMERCIALIZATION
Our scientists and engineers are there from concept to commercialization, providing development services, material supply aligned with GMP principles and regulatory support.
Media Partners
FemTech Collective
Website: https://femtechcollective.com/
FemTech Collective is the world’s largest network for entrepreneurs, innovators, and professionals interested in amplifying the women’s health technology ecosystem. Our mission is to catalyze quality innovation by providing a strategic platform for the FemTech ecosystem in order to create and grow better products and services to accelerate female health.
Femtech Insider
Website: https://femtechinsider.com/
Femtech Insider is the go-to platform for all things femtech. We’re the fastest growing portal for innovation in women’s health and address the information needs of founders, investors, researchers and consumers alike.
Frost and Sullivan
Website: https://ww2.frost.com/
For over five decades, Frost & Sullivan has become world-renowned for its role in helping investors, corporate leaders and governments navigate economic changes and identify disruptive technologies, Mega Trends, new business models and companies to action, resulting in a continuous flow of growth opportunities to drive future success.
Springboard Enterprises
Website: https://sb.co/
Springboard’s mission is to accelerate the growth of entrepreneurial companies led by women through access to essential resources and a global community of experts. It is the leading network of influencers, investors and innovators dedicated to building high-growth companies led by women who are transforming industries in technology and life science.
Women's Health Innovation Coalition
Website: https://www.womens.health/
We are a coalition of organizations advocating and promoting greater attention, research, and investment in diseases, conditions, and indications that exclusively or predominantly impact women. Understanding that women are biologically different than their male counterparts, has led to the identification of gaps in women’s health outcomes. This has created new opportunities to fill these gaps through sourcing solutions from innovators. We have made it a priority to prove that women’s health is not a niche market and are driving initiative to promote greater gender-relevant data transparency to spur innovation and better health outcomes for all.
WOMEN'S HEALTH INNOVATION SERIES 2021 CALENDAR
Speakers
Susan C. Nicholson MD FIDSA
Lesley Jane Seymour
Dr. Barb DePree
Dr. Jane van Dis, MD
Jill Angelo
Dr. Pam Peeke
Dr. Brian A. Bernick
Dr. Brian Bernick is a graduate of Northwestern University where he was pre-med and earned a degree in economics. Dr. Bernick graduated from Chicago Medical School and then went on to specialize in obstetrics and gynecology, completing his residency through the University of Pennsylvania. Thereafter, Dr. Bernick spent over 20 years in private practice in Boca Raton, Florida. During that time, he served as the Chairman of the Department of Obstetrics and Gynecology at Boca Raton Regional Hospital and as an associate professor at Florida Atlantic University College of Medicine. In 2008, Dr. Bernick co-founded TherapeuticsMD, a woman’s healthcare company where he has remained part of the executive management and oversees product development and outreach with healthcare providers. TherapeuticsMD is a NASDAQ traded pharmaceutical company with prescription drug products ranging from prenatal care, contraception and menopause. In 2018, TherapeuticsMD obtained 3 new drug approvals. Dr. Bernick is the recipient of several national and regional awards, including recognition by his peers as one of the top doctor’s in his specialty. Dr. Bernick has over 100 peer-reviewed publications and presentations of original research at medical conferences. Dr. Bernick holds over 40 US and foreign patents focusing on drug therapies and analysis. Dr. Bernick resides in Boca Raton, Florida with his wife and two kids.
Dr. Jen Gunter
Lisa Larkin
Reenita Das
Missy Lavender
Holly J. Pederson M.D.
Dr Elizabeth Mueller
Karen Giblin
Marta Hill Gray
Rachel Braun Scherl
Barbara Dehn
Barb Dehn is a practicing Women’s Health Nurse Practitioner in Silicon Valley and a television health expert, who’s known as Nurse Barb on NBC’s California Live. An award winning author, active in Social Media and YouTube, Barb earned a masters degree from UCSF and a BS from Boston College. She is certified by the North American Menopause Society and is a Fellow in the American Association of Nurse Practitioners. She works on Global Health Initiatives at FAME Hospital in Karatu, Tanzania, where she serves on their board and as a volunteer.
Allison Conti
Bill Gruber
Bill Gruber joined Solace Therapeutics in August 2011 as President and CEO. Prior to this role, he co-founded Interlace Medical in August 2006 and served as their President and CEO until Interlace was acquired by Hologic in January 2011. Bill has extensive experience in organizational development and in product development for rapid growth businesses. Prior to Interlace, Bill spent five years at Cortek Inc., a spinal products company. As Cortek’s V.P. of Sales and Marketing, he built sales from $612K to over $10M. During his last two years, he was the V.P. of New Business Development and Marketing. In this role, he was instrumental in creating Soteira, a Cortek subsidiary, focused on devices for treating vertebral compression fractures. Prior to Cortek, Bill spent 10 years at Boston Scientific Corporation. Before leaving Boston Scientific Corporation, he held the position of Director of the $172M Global Atherosclerotic Therapy business. Prior to entering the medical device sector, Bill spent five years in sales and marketing roles at Procter and Gamble.
Colette Courtion
Rochelle Weitzner
Beth Battaglino
Dr. Irene W. Bean
Dr Mary Jane Minken
Cherin Smith
JoAnn V. Pinkerton, MD, FACOG, NCMP
Tracy Chadwell
Dr. R. Faye
Dr. Smita Patel
Kathryn G. Schubert, MPP
Sateria Venable
Juan Camilo Arjona Ferreira
Kathy Abernethy
Sonsoles Gonzalez
Anna Klepchukova
Dr. Jessica Shepherd
Christine Marie Mason
Jannine Versi
DOWNLOAD AGENDA
Download the agenda for the Women 40+ Innovation Summit, taking place virtually this June 22-23.
Take a look at 2019 highlights:
Download the agenda
TICKET PACKAGES
Sending Your Team? Group Discounts Available!
Applicable for Primary Market, Service Provider and Industry Rates Only. Not available for Academic or ‘Start-Up’ rates
Book a Team of 3+ - Save an Additional 10% Off
Book a Team of 5+ - Save an Additional 15% Off
If you would like to register a team of 3 or more, please email [email protected] for your discount coupon code before registering. PLEASE NOTE: Discounts cannot be combined with Early Bird Pricing or any other discount or offer. If you have any questions about your registration, please call us on +44 (0)20 3696 2920
The Virtual Experience
Top 10 benefits
- Tailor Your Agenda
- More Audience Participation
- Improved Audience Visibility
- On-Demand Content
- High Quality Speakers
- More Networking Opportunities
- Save Time & Money
- Increased Content
- More insights
- Business Development Opportunities - Talk to our team to find out out more [email protected].
Platform Preview
BECOME A MEDIA PARTNER
If you're interested in becoming a media partner, please contact Kat Rhomberg: [email protected]
Become a Partner
Kisaco Research provides the much-needed platform on which industry executives can network, connect and learn from each other as well as meet potential industry partners.
Far from the typical ‘meet-and-greet’ exhibition experience, you – as a sponsor or exhibitor – will be positioned as a partner of the event with a focus on the benefits of your product and brand, rather than just a name on an exhibition list.
With our extensive marketing experience and strategy, your partnership with Kisaco Research will grant you a sponsorship package that is an extension and enhancement of your current marketing and branding efforts. We value your ROI and will work with you directly on your specific goals and targets – that’s why we take special care in finding the most relevant end-users to attend, so that your financial and resource investment is smartly allocated.
Find out more by calling us at +44 (0)20 3696 2920 or email us at [email protected].
About Kisaco Research
Kisaco Research produces, designs and hosts B2B industry conferences, exhibitions and communities – focused on a specialized selection of topic areas.
Meet industry peers that will help build a career-changing network for life.
Learn from the mistakes of your peers as much as their successes—ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.
Note down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.
Invest both in your company growth and your own personal development by signing up to one of our events and get started.